#arrhythmias--Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today unveiled a comprehensive schedule of educational content and sessions featuring the use of vMap
Data Demonstrates vMap’s Ability to Locate Arrhythmia Sources and Deliver Critical Value
SAN DIEGO: #arrhythmias--Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today unveiled a comprehensive schedule of educational content and sessions featuring the use of vMap® at this year’s Heart Rhythm 2024 conference in Boston, May 16-19.
vMap rapidly provides actionable arrhythmia localization insights for physicians. The research and presentations at HRS further demonstrate the unique ability of vMap to assist physicians with both focal and fibrillation-type arrhythmias. Attendees can experience vMap at the Vektor Medical booth (#669), hear expert perspectives from leading KOLs during the Rhythm Theater, and read more about vMap in various scientific posters and presentations. Details follow:
“The Future of Care: Leveraging AI for Arrhythmia Localization”
Rhythm Theater Symposium | Friday, May 17 | 4:00 – 5:00 p.m.
Discover how vMap integrates intelligently into existing workflows, elevating patient care and streamlining procedures. An expert panel including Drs. Gery Tomassoni, Ulrika Birgersdotter-Green, Jag Singh, Ben D’Souza, John Miller, and David Krummen will discuss the transformative power of AI-driven ECG analysis, shaping the future of ablations, enhancing efficiencies, and optimizing outcomes.
Scientific Posters and Abstract Presentations
Friday, May 17
Saturday, May 18
Sunday, May 19
“HRS is a vital opportunity for us to connect with the electrophysiology community, share our latest data, and receive invaluable feedback,” said Rob Krummen, CEO of Vektor Medical. “Our team is deeply committed to advancing cardiac care, and I’m excited to see how vMap continues to improve patient outcomes and streamline procedures. Our program of activities at HRS illustrates the transformative power of vMap, both in tangible clinical results and the broader, intangible benefits it brings to the healthcare landscape.”
For more information about vMap or to meet with Vektor Medical at HRS 2024, please visit booth 669, contact us here, and connect on LinkedIn.
About vMap®
vMap is the only FDA-cleared, non-invasive AI-based solution for mapping arrhythmias, utilizing just a 12-lead ECG. vMap localizes arrhythmia sources for focal and fibrillation-type arrhythmias, including atrial fibrillation. By unlocking actionable insights contained within a standard 12-lead ECG, vMap enables physicians to rapidly and accurately locate arrhythmia source locations. Backed by extensive clinical evidence, vMap not only improves patient outcomes but also reduces procedure time, optimizing workflow across the entire arrhythmia care pathway.
About Vektor Medical
Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. For more information about vMap and Vektor Medical, please visit www.vektormedical.com.
Follow Vektor Medical: LinkedIn and Twitter/X.
Fonte: Business Wire
Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE
The Italian IoT company is in the US for the second phase of CALL4INNOVIT
The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming
Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…
The "New Zealand Buy Now Pay Later Business and Investment Opportunities Databook - Q2 2024 Update" report has been added to ResearchAndMarkets.com's…
The "Kenya Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis,…
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.…
RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that Mark Lawyer has joined…